Oncotarget

Research Papers:

Antioxidant and pro-angiogenic effects of corilagin in rat cerebral ischemia via Nrf2 activation

Yi Ding, Danjun Ren, Hang Xu, Wenxing Liu, Tianlong Liu, Liang Li, Jianguang Li _, Yuwen Li and AiDong Wen

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:114816-114828. https://doi.org/10.18632/oncotarget.22023

Metrics: PDF 432 views  |   HTML 1342 views  |   ?  


Abstract

Yi Ding1,*, Danjun Ren1,2,*, Hang Xu1,*, Wenxing Liu1,*, Tianlong Liu1,*, Liang Li1, Jianguang Li2, Yuwen Li1 and AiDong Wen1

1Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi’an 710032, China

2XinJiang Medical University, Wulumuqi 830001, China

*These authors have contributed equally to this work

Correspondence to:

Jianguang Li, email: L77117@163.com

Yuwen Li, email: liyuwenzs@gmail.com

AiDong Wen, email: adwen-2004@hotmail.com

Keywords: corilagin; Nrf2; oxidative stress; angiogenesis; ischemic stroke

Received: August 06, 2017    Accepted: September 23, 2017    Published: October 24, 2017

ABSTRACT

The nuclear factor erythroid-2-related factor 2 (Nrf2) pathway has been considered as a potential target for neuroprotection in stroke. The aim of present study was to determine whether corilagin, a novel Nrf2 activator, can protect against ischemia-reperfusion injury and explore the underlying mechanism involved. In vivo, rats exposed to middle cerebral artery occlusion were applied to establish an ischemic stroke model. Posttreatment of corilagin significantly reduced infarct volumes and apoptotic cells as well as improved neurologic score after reperfusion, together with increased vascular density in the ischemic penumbra. Meanwhile, posttreatment with corilagin in MCAO rats significantly decreased malondialdehyde levels, restored the superoxide dismutase and glutathione activity, elevating the Nrf2, heme oxygenase-1, the vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2) expression. However, consecutive intrathecal injection of short interference RNAs targeting Nrf2 at 24-h intervals 72 h before ischemia reduced the beneficial effects of corilagin. In primary cultured neurons, corilagin dose-dependently protected against oxygen and glucose deprivation-induced insult, but the protective effect of corilagin was attenuated by knockdown of Nrf2. In conclusion, these findings indicate that corilagin exerts protective effects against cerebral ischemic injury by attenuating oxidative stress and enhancing angiogenesis via activation of Nrf2 signaling pathway.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22023